Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Abstract Background Maintaining the dose-intensity of cancer treatment is an important prognostic factor of aggressive hematological malignancies. The objective of this study was to assess the long-term outcomes of intensive care unit (ICU) survivors with acute myeloid leukemia (AML) or aggressive B...

Full description

Bibliographic Details
Main Authors: Swann Bredin, Justine Decroocq, Clément Devautour, Julien Charpentier, Clara Vigneron, Frédéric Pène
Format: Article
Language:English
Published: SpringerOpen 2024-09-01
Series:Annals of Intensive Care
Subjects:
Leukemia
Lymphoma
Chemotherapy
Outcome
ICU
Online Access:https://doi.org/10.1186/s13613-024-01372-5

Internet

https://doi.org/10.1186/s13613-024-01372-5

Similar Items